Viewing StudyNCT00267722



Ignite Creation Date: 2024-05-05 @ 12:10 PM
Last Modification Date: 2024-10-26 @ 9:21 AM
Study NCT ID: NCT00267722
Status: COMPLETED
Last Update Posted: 2012-03-07
First Post: 2005-12-19

Brief Title: Visilizumab for Moderate to Severe Inflammatory Nonstricturing Nonpenetrating Crohns Disease
Sponsor: Facet Biotech
Organization: Facet Biotech

Conditions & Keywords Data

Conditions:
Name
Crohns Disease
Keywords: